We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.93%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.42B
AUM Growth
+$6M
(+0.18%)
Cap. Flow
-$56.5M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
23.69%
Holding
516
New
65
Increased
98
Reduced
233
Closed
68
Avg Time Held
1.4
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$65.1M |
| 2 |
Las Vegas Sands
LVS
|
+$37.7M |
| 3 |
Thor Industries
THO
|
+$34.6M |
| 4 |
Lear
LEA
|
+$33.5M |
| 5 |
Idexx Laboratories
IDXX
|
+$32.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Campbell Soup
CPB
|
+$60.2M |
| 2 |
Lowe's Companies
LOW
|
+$57.7M |
| 3 |
Clorox
CLX
|
+$44.5M |
| 4 |
Darden Restaurants
DRI
|
+$39.4M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$37.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 16.69% |
| 4 | Industrials | 13.06% |
| 5 | Consumer Staples | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Ormat Technologies
ORA
$5.53B
| $616K | 0.02% |
+11,480
| New | +$558K |
2016 Q4
0 quarters
|
|
177
Dorman Products
DORM
$3.64B
| $611K | 0.02% |
8,360
-100
| -1% | -$6.83K |
2016 Q3
1 quarter
|
|
178
Ultragenyx Pharmaceutical
RARE
$1.45B
| $609K | 0.02% |
8,660
-100
| -1% | -$7.09K |
2015 Q4
4 quarters
|
|
179
First Community Bankshares
FCBC
$921M
| $573K | 0.02% |
19,000
-913
| -5% | -$24.4K |
2013 Q2
14 quarters
|
|
180
World Acceptance Corp
WRLD
$804M
| $550K | 0.02% |
8,560
-490
| -5% | -$27.5K |
2013 Q2
14 quarters
|
|
|
BSTC
181
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $545K | 0.02% |
9,788
-300
| -3% | -$14.4K |
2014 Q1
11 quarters
|
|
182
Stock Yards Bancorp
SYBT
$2.38B
| $532K | 0.02% |
11,335
-360
| -3% | -$14.1K |
2013 Q3
13 quarters
|
|
183
Archrock
AROC
$5.15B
| $523K | 0.02% |
39,610
-7,650
| -16% | -$98.7K |
2016 Q2
2 quarters
|
|
184
Ezcorp Inc
EZPW
$2.03B
| $515K | 0.02% |
48,310
-10,120
| -17% | -$109K |
2016 Q2
2 quarters
|
|
185
Molina Healthcare
MOH
$10.8B
| $508K | 0.01% |
9,360
+900
| +11% | +$49.2K |
2015 Q2
6 quarters
|
|
186
REX American Resources
REX
$1.38B
| $498K | 0.01% |
30,240
-960
| -3% | -$14.3K |
2014 Q3
9 quarters
|
|
187
First Financial Corp
THFF
$881M
| $488K | 0.01% |
9,250
-63,513
| -87% | -$2.84M |
2014 Q2
10 quarters
|
|
188
Interparfums
IPAR
$3.67B
| $485K | 0.01% |
+14,800
| New | +$490K |
2016 Q4
0 quarters
|
|
189
Tilly's
TLYS
$142M
| $471K | 0.01% |
35,690
+17,000
| +91% | +$189K |
2015 Q1
7 quarters
|
|
190
Pathward Financial
CASH
$1.51B
| $466K | 0.01% |
+13,590
| New | +$380K |
2016 Q4
0 quarters
|
|
191
US Physical Therapy
USPH
$1.27B
| $466K | 0.01% |
6,637
-1,790
| -21% | -$114K |
2013 Q2
14 quarters
|
|
192
DELISTED
ARC Document Solutions, Inc.
ARC
| $460K | 0.01% |
90,610
-2,910
| -3% | -$12.2K |
2016 Q2
2 quarters
|
|
|
ARIA
193
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $451K | 0.01% |
36,250
| – | – |
2016 Q2
2 quarters
|
|
194
Arrow Financial
AROW
$686M
| $446K | 0.01% |
13,553
-443
| -3% | -$13K |
2013 Q3
13 quarters
|
|
195
Exelixis
EXEL
$15.4B
| $439K | 0.01% |
29,410
| – | – |
2015 Q3
5 quarters
|
|
196
Bel Fuse Inc Class B
BELFB
$3.02B
| $437K | 0.01% |
14,150
-520
| -4% | -$14.5K |
2016 Q3
1 quarter
|
|
197
Ironwood Pharmaceuticals
IRWD
$592M
| $437K | 0.01% |
34,148
| – | – |
2016 Q1
3 quarters
|
|
198
OFG Bancorp
OFG
$2.23B
| $403K | 0.01% |
+30,740
| New | +$369K |
2016 Q4
0 quarters
|
|
199
Ennis
EBF
$568M
| $401K | 0.01% |
23,109
+21,920
| +1,844% | +$357K |
2015 Q4
4 quarters
|
|
200
Ligand Pharmaceuticals
LGND
$5.88B
| $399K | 0.01% |
6,300
| – | – |
2016 Q1
3 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, Smith Group Asset Management held 516 positions worth $3.42B, up 0.18% from $3.41B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Smith Group Asset Management's Q4 2016 filing shows 65 new, 98 increased, 233 reduced and 68 closed positions. Its largest new stake was Las Vegas Sands: 646,630 shares worth $34.5M. The largest sale was Campbell Soup, an estimated $60.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Smith Group Asset Management's largest Q4 2016 buy was Las Vegas Sands: 646,630 shares worth $34.5M.
- Smith Group Asset Management added most to Target in Q4 2016, an estimated $65.1M increase.
- Smith Group Asset Management's biggest Q4 2016 reduction was Clorox, cutting an estimated $44.5M.
- Smith Group Asset Management fully exited Campbell Soup in Q4 2016, selling an estimated $60.2M.
- Smith Group Asset Management's ten largest holdings make up 24% of its $3.42B portfolio in Q4 2016.
- Smith Group Asset Management opened 65 new positions and closed 68 in Q4 2016.
- Smith Group Asset Management's portfolio value rose 0.18% quarter-over-quarter to $3.42B.
Based on Smith Group Asset Management's 13F filing for Q4 2016, filed 31 Jan 2017.